Clinical Trial Update: Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating topiramate for post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Tuscaloosa Research & Education Advancement Corporation | Conditions: PTSD | Phase 4 | Status: COMPLETED